Camurus Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Camurus's estimated annual revenue is currently $25.5M per year.
- Camurus's estimated revenue per employee is $201,000
- Camurus has 127 Employees.
- Camurus grew their employee count by 38% last year.
- Camurus currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is Camurus?
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.keywords:N/A
Number of Employees
Employee Growth %
LUND, Sweden, Aug. 26, 2019 /PRNewswire/ -- The Australian Federal Health Minister Greg Hunt announced on Sunday that Camurus' ...
Camurus AB (publ)'s (STO:CAMX): Camurus AB (publ), a research-based pharmaceutical company, develops and commercializes ...
Camurus AB (publ) (OM:CAMX) has posted year over year net profit growth of 0.37383. The net profit number is the nuts and bolts of a firm's ...